Cite

HARVARD Citation

    Basenach, E. et al. (n.d.). INNV-06. TREATMENT RESPONSE TO BEVACIZUMAB OVER TWO YEARS IN A PATIENT WITH GENETICALLY PROVEN SOMATIC NEUROFIBROMATOSIS TYPE 2 MOSAICISM. Neuro-oncology. p. vi131. [Online]. 
  
Back to record